Blog
About

  • Record: found
  • Abstract: found
  • Article: found
Is Open Access

Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins

Read this article at

Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      The heterogeneous group of diseases collectively termed cancer results not just from aberrant cellular proliferation but also from a lack of accompanying homeostatic cell death. Indeed, cancer cells regularly acquire resistance to programmed cell death, or apoptosis, which not only supports cancer progression but also leads to resistance to therapeutic agents. Thus, various approaches have been undertaken in order to induce apoptosis in tumor cells for therapeutic purposes. Here, we will focus our discussion on agents that directly affect the apoptotic machinery itself rather than on drugs that induce apoptosis in tumor cells indirectly, such as by DNA damage or kinase dependency inhibition. As the roles of the Bcl-2 family have been extensively studied and reviewed recently, we will focus in this review specifically on the inhibitor of apoptosis protein (IAP) family. IAPs are a disparate group of proteins that all contain a baculovirus IAP repeat domain, which is important for the inhibition of apoptosis in some, but not all, family members. We describe each of the family members with respect to their structural and functional similarities and differences and their respective roles in cancer. Finally, we also review the current state of IAPs as targets for anti-cancer therapeutics and discuss the current clinical state of IAP antagonists.

      Related collections

      Most cited references 248

      • Record: found
      • Abstract: found
      • Article: found

      Hallmarks of Cancer: The Next Generation

      The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer. Copyright © 2011 Elsevier Inc. All rights reserved.
        Bookmark
        • Record: found
        • Abstract: not found
        • Article: not found

        The hallmarks of cancer.

          Bookmark
          • Record: found
          • Abstract: found
          • Article: not found

          Autophagy in the pathogenesis of disease.

          Autophagy is a lysosomal degradation pathway that is essential for survival, differentiation, development, and homeostasis. Autophagy principally serves an adaptive role to protect organisms against diverse pathologies, including infections, cancer, neurodegeneration, aging, and heart disease. However, in certain experimental disease settings, the self-cannibalistic or, paradoxically, even the prosurvival functions of autophagy may be deleterious. This Review summarizes recent advances in understanding the physiological functions of autophagy and its possible roles in the causation and prevention of human diseases.
            Bookmark

            Author and article information

            Affiliations
            [1 ]NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA, 92037, USA
            Author notes

            *These authors contributed equally

            Competing interests: No competing interests were disclosed.

            Journal
            F1000Res
            F1000Res
            F1000Research
            F1000Research
            F1000Research (London, UK )
            2046-1402
            27 April 2017
            2017
            : 6
            5414821
            10.12688/f1000research.10625.1
            Copyright: © 2017 Finlay D et al.

            This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

            Product
            Funding
            Funded by: National Institutes of Health
            Award ID: R01CA195227
            This work was supported by National Institutes of Health grant R01CA195227 to DF and NDPC.
            The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
            Categories
            Review
            Articles
            Cancer Therapeutics
            Cell Growth & Division
            Cellular Death & Stress Responses
            Drug Discovery & Design
            Molecular Pharmacology

            Comments

            Comment on this article